2Brown DW, Croft JB, Greenlund K J, et al. Trends in hospi- talization with chronic obstructive pulmonary disease - United States, 1990 - 2005. COPD,2010, 7:59 - 62.
3Polednak AP. Trends in mortality from COPD in selected U. S. states differing in tobacco control efforts. COPD,2010,7: 63 - 69.
4O, Driscoll BR, Kay EA, Taylor RJ, et al. A long - term pro- spective assessment of home nebuliger treatment. Respir Med,1992,86(4) :317.
5Tashkin DP, Celli B, Senn S, et al. A 4 - year trial of tiotropium in chronic obstructive puhnonary disease. N Engl J Med 2008,359:1543 - 1554.
6Wu Q, Li G, Lei WI, el al. The efficacy anti satety oftiotropium in Chinese patients with stable COPD : a meta - a- nalysis. Respirology,2009,14:666 - 674.
7Barr RG, Bourbcau J. Camergp CA. Tiotropium for stable chronic obstructive pulmonary disease, A mete- analysis. Thorax ,2006,61 (10) :854 - 862.
8Zhou YM, Wang XP, Zeng XY, et al. Positive benefits of theophylline in a randomized, double - blind, parallel - group, placebo - controlled study of low - dose, slow - re- lease theophylline in the treatment of COPD for 1 year. Re- spirology,2006,11, 603 - 610.
5Vachier I, Kumlin M, Dahlen SE, et al. High levels of urinary leukotriene E4 excretion in steroid treated pa- tients with severe asthma [ J ]. Respir Med, 2003,97 (11):1 225-1229.
6Capra V, Ambrosio M, Riccioni G, et al. Cysteinyl-leukotriene receptor antagonists:present situation and future opportunities[ J]. Curr Med Chem ,2006,13 (26) : 3 213 -3 226.
7Thompson C, Cloutier A, Bosse Y, et, al. CysLT1 receptor engagement induces activator protein-1-and NF-kappaB -dependent IL-8 expression[ J]. Am J Respir Cell Mol Biol,2006,35 (6) :697 - 704.
8[1]Anzueto A.Clinical course of chronic obstructive pulmonary disease:review of therapeutic interventions[J].Am J Med,2006,119(10):46-53.
9[2]Anthonisen NR,Skeans MA,Wise RA,et al.The effects of a smoking cessation intervention on 14.5-year mortality:a randomized clinical trial[J].Ann Intern Med,2005,142(4):233-239.
10[3]Campos MA,Wanner A.The rationale for pharmacologic therapy in stable chronic obstructive pulmonary disease[J].Am J Med Sci,2005,329(4):181-189.
